SOLACI

idioma

15 Must read articles

SOLACI
MEMBERS
- Become a Member
- Professionals Directory
CONGRESS
View all
- SOLACI-SBHCI 23 - 01 / 08 / 2023
- SOLACI-SOCIME 22 - 03 / 08 / 2022
- SOLACI-CACI 21 - 13 / 09 / 2021
- SOLACI-SBHCI 2019 - 17 / 04 / 2019
- SOLACI-SOCIME’18 - 12 / 04 / 2018
View all
- ACC 2024 - 09 / 04 / 2024
- AHA 2023 - 13 / 11 / 2023
- TCT 2023 - 24 / 10 / 2023
- ESC 2023 - 28 / 08 / 2023
- EuroPCR 2023 - 17 / 05 / 2023
View all
- SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17 - 25 / 04 / 2024
- EuroPCR 2024 – from May 14th to 17th in Paris - 05 / 04 / 2024
- Cli-C Global 2024 - 21 / 02 / 2024
- Structural Summit 2024 – Deadline Extended: One More Week to Submit Your Work - 05 / 02 / 2024
- Structural Summit 2024: Disruptive Innovations, Complex Interventions - 16 / 01 / 2024
View all
View all
SESSIONS
- About Regional Sessions
- Sessions
View all
- Peru Sessions 2023 - 27 / 10 / 2023
- Dominican Republic Sessions 2023 – All You Should Know - 06 / 09 / 2023
- Colombia Sessions 2022 - 18 / 08 / 2022
- Paraguay 2022 Sessions - 01 / 04 / 2022
- Mexico Sessions 2021 - 02 / 12 / 2021
View all
ProEducar
SOLACI Research
PUBLICATIONS
View all
View all
- Angiografia coronaria cuantitativa: métodos y aplicaciones - 28 / 09 / 2015
- Ultrasonido Intravascular - 28 / 09 / 2015
- Placa vulnerable: definición, diagnóstico y tratamiento. - 28 / 09 / 2015
- Stents coronarios: indicaciones actuales - 28 / 09 / 2015
- Trombosis del stent. Antes y después de los stents farmacológicos - 28 / 09 / 2015
View all
- JSHD | JOURNAL OF STRUCTURAL HEART DISEASE - 03 / 12 / 2019
- EuroIntervention. Official Publication of EuroPCR & EAPCI - 29 / 11 / 2019
- JACC | Journal of the American College of Cardiology - 28 / 11 / 2019
- CCI | Catheterization and Cardiovascular Interventions - 27 / 11 / 2019
- REC | Interventional Cardiology - 26 / 11 / 2019
View all
NURSES AND TECHNICIANS
Contact

LATEST NEWS

ERCTO Registry: Chronic Total Occlusion Treatment Outcomes
Carotid Endarterectomy vs. Carotid Angioplasty in Symptomatic and Asymptomatic Patients: 30-Day Outcomes
EXCEL Study: Complete vs. Incomplete Revascularization
Drug-Coated Balloon Angioplasty in Femoropopliteal CTOs: Intraluminal or Subintimal?
SMART Trial: What is the Best Valve for Small Annuli?
Peripheral Vascular Disease: Our Reality in Latin America, with the LATAM SOLACI Peripheral Registry
ACC 2024 | ORBITA-COSMIC

File
Heart Disease
Peripheral vascular disease
Pharmacology
Structural heart disease
All the articles

The Approved Use of Actual DES in Complex Subgroups: Diabetics, ISR, Bifurcation

Day 2

24 / 06 / 2015

Descargar (PDF, Unknown)

J. Belardi
2012-08-09

Cancel reply

Your Name *

Your Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Related Articles

Drug Eluting Balloon for the Side Branch in Provisional Stent Strategy: Rationale and Current Evidence

Bifurcation-Dedicated Stents: an Description of the Clinically Available Devices and of their Performance.

Strategies for Switching Antiplatelet Treatment Regimens in the Setting of ACS, and Its Implications

Mechanical Thrombectomy with the AngioJet Device in AMI with a Glimpse of Other Described Applications

This may interest you

SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17

25.04.2024

¿Se justifica utilizar filtro de protección distal en los puentes venosos?

ERCTO Registry: Chronic Total Occlusion Treatment Outcomes

25.04.2024

Carotid Endarterectomy vs. Carotid Angioplasty in Symptomatic and Asymptomatic Patients: 30-Day Outcomes

24.04.2024

¿La elevación de marcadores luego de una angioplastia electiva no debería preocuparnos?

EXCEL Study: Complete vs. Incomplete Revascularization

24.04.2024

Nuevas estrategias en el territorio femoropoplíteo

Drug-Coated Balloon Angioplasty in Femoropopliteal CTOs: Intraluminal or Subintimal?

19.04.2024

Anillos aórticos pequeños, ¿Qué válvula deberíamos elegir?

SMART Trial: What is the Best Valve for Small Annuli?

19.04.2024

Enfermedad vascular periférica: nuestra realidad en LATAM. Registro LATAM SOLACI Peripheral

Peripheral Vascular Disease: Our Reality in Latin America, with the LATAM SOLACI Peripheral Registry

18.04.2024

ACC 2024

ACC 2024 | ORBITA-COSMIC

17.04.2024

ACC 2024

ACC 2024 | IVUS-DCB

17.04.2024

ACC 2024

ACC 2024 | REDUCE AMI: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

16.04.2024

The Visible Heart Lab

04/23 – SOLACI-Medtronic Webinar | The Visible Heart Lab. Register now

16.04.2024

ACC 2024

ACC 2024 | SMART Trial: Self-Expanding or Balloon-Expandable TAVR in Patients with Small Aortic Annulus

12.04.2024

This may interest you

SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17

¿Se justifica utilizar filtro de protección distal en los puentes venosos?

ERCTO Registry: Chronic Total Occlusion Treatment Outcomes

Carotid Endarterectomy vs. Carotid Angioplasty in Symptomatic and Asymptomatic Patients: 30-Day Outcomes

¿La elevación de marcadores luego de una angioplastia electiva no debería preocuparnos?

EXCEL Study: Complete vs. Incomplete Revascularization

Nuevas estrategias en el territorio femoropoplíteo

Drug-Coated Balloon Angioplasty in Femoropopliteal CTOs: Intraluminal or Subintimal?

MOST READ POSTS

When and How to Switch Dual Antiplatelet Therapies
ACC 2024 | DEDICATE Trial: Transcatheter or Surgical Treatment of Aortic Valve Stenosis
ACC 2024 | DanGer-Shock Trial
ACC 2024 | PREVENT Study
ACC 2024 | REDUCE AMI: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

LATEST TWEETS

SOLACI Follow

Somos la Sociedad Latinoamericana de Cardiología Intervencionista y bregamos por promover el intervencionismo cardiovascular en América Latina y el Caribe.

SOLACI @solaci3 ·

⭐ Nuevo artículo en https://solaci.org
▶ TAVI en los diferentes tipos de estenosis aórtica
▶ Por el Dr. Carlos Fava
https://buff.ly/3PRvuIy

Reply on Twitter 1776037066704367937 Retweet on Twitter 1776037066704367937 1 Like on Twitter 1776037066704367937 5 Twitter 1776037066704367937

SOLACI @solaci3 ·

▶ ¡Solo quedan 2 días para el cierre del Call4science del SOLACI-CACI 2024!
▶ Presente su trabajo y comparta sus conocimientos con los más importantes expertos de la cardiología intervencionista del continente
¡No se quede afuera!
https://buff.ly/3U1XXhd

Reply on Twitter 1775957609679331784 Retweet on Twitter 1775957609679331784 Like on Twitter 1775957609679331784 5 Twitter 1775957609679331784

SOLACI @solaci3 ·

▶ Nuevo artículo en https://solaci.org
▶ Paclitaxel y mortalidad en vascular periférico: ¿Debate cerrado?
▶ Por el Dr. @tupayachi_omar
https://buff.ly/3J4OUpt

Reply on Twitter 1775674146640298049 Retweet on Twitter 1775674146640298049 1 Like on Twitter 1775674146640298049 3 Twitter 1775674146640298049

SOLACI @solaci3 ·

▶ ¡Solo 3 días para el cierre del Call4science SOLACI-CACI 2024!
🕐 Aún tiene tiempo para enviar su trabajo y ser parte del evento de cardiología intervencionista más grande de América Latina.
✅ ¡Importantes premios para los ganadores!
https://buff.ly/3TLPtcv

Reply on Twitter 1775625278410137801 Retweet on Twitter 1775625278410137801 1 Like on Twitter 1775625278410137801 1 Twitter 1775625278410137801

SOLACI
Day 2
The Approved Use of Actual DES in Complex Subgroups: Diabetics, ISR, Bifurcation

What is SOLACI?
About us
Bylaws
Editorial Board
Affiliated Countries
Institutional News

Become a member
Professionals Directory

SOLACI Congresses
International Congresses

About Regional Sessions
Presentations

About ProEducar
ProEducar Educational Newsletter
News

Publications
Nurses and Technicians
Patients

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 49547173 ·info@solaci.org -solaci.org -Términos de uso -Políticas de privacidad

SOLACI Latin American Society of Interventional Cardiology · Copyright © 2024. All rights reserved.

Top